Business / Finance

RSS

National Surgical Hospitals purchases interest in The Fairfield Surgery Center

National Surgical Hospitals, Inc., an owner, operator and developer of surgery centers and surgical hospitals in partnership with local physicians, today announced that it has purchased an interest in The Fairfield Surgery Center, LLC located in Fairfield, Connecticut.

28 May 2014

PCI | HealthDev adds Greg Pakes as Controller

PCI | HealthDev™ formerly Physicians' Capital Investments® (the Company), a leader in medical real estate development and medical investment solutions, is pleased to announce the addition of Greg Pakes as Controller.

28 May 2014

MRA announces acquisition of TrustHCS's cancer registry services division

Medical Record Associates, LLC, (MRA) announces the acquisition of TrustHCS's cancer registry services division. The acquisition of TrustHCS's cancer registry business compliments and expands MRA's existing cancer registry service offerings which assist healthcare customers in maintaining registry compliance, staffing registry programs and preparing for ACoS surveys.

28 May 2014

FDA postpones Dispute Resolution Panel for FzioMed’s Oxiplex PMA

FzioMed, Inc. today announced it has agreed with the Center for Devices and Radiological Health (CDRH) of the U.S. Food and Drug Administration (FDA) to postpone the Dispute Resolution Panel for its Oxiplex PMA; the meeting was previously scheduled for June 10.z

28 May 2014

Trimel announces top-line results of Phase II clinical trial evaluating efficacy of Tefina

Trimel Pharmaceuticals Corporation (TSX: TRL) announced today top-line results of its Phase II clinical trial evaluating the efficacy and safety of Tefina™, a "use-as-required" testosterone nasal gel for the treatment of Female Orgasmic Disorder (FOD).

28 May 2014

Spokane Valley Cancer Center partners with SCCA Network to become 12th Member in Northwest

Spokane Valley Cancer Center joined the Seattle Cancer Care Alliance (SCCA) Network to become its 12th Member in the Northwest this month. This relationship will expand access to cancer treatment options and help foster advances in cancer care in the greater Spokane community.

28 May 2014

Twist Bioscience raises $26M in Series B financing, receives $5.1M DARPA contract

Twist Bioscience today announced that it raised $26 million in a Series B financing to commercialize the company's semiconductor-based synthetic gene manufacturing process.

27 May 2014

Alligator Bioscience acquires rights to drug development candidate ADC-1013

BioInvent International AB (publ) (OMXS:BINV) today announced that the company has sold back all its rights to drug development candidate ADC-1013 to former partner Alligator Bioscience for an undisclosed sum.

27 May 2014

Abiogen Pharma, Lee's Pharma sign deal to market Neridronic Acid

Abiogen Pharma S.p.A. of Pisa Italy and Lee's Pharm jointly announced the agreement for License, Distribution and Supply for marketing of Attila® (Neridronic Acid) throughout China, Hong Kong, Macau and Taiwan.

27 May 2014

Inovio Pharmaceuticals proposes 1-for-4 reverse split of common stock

Inovio Pharmaceuticals, Inc. today announced that at the Company's Annual General Meeting held May 22, 2014, the Company's shareholders approved the proposal of a reverse split of the Company's common stock.

23 May 2014

Zimmer Holdings proposes to pay quarterly cash dividend to stockholders for Q2 of 2014

Zimmer Holdings, Inc., a global leader in musculoskeletal care, today announced that its Board of Directors has approved the payment of a quarterly cash dividend to stockholders for the second quarter of 2014.

23 May 2014

iRhythm Technologies closes $17 million Series E financing

iRhythm Technologies, Inc., a healthcare information services company, today announced that it closed a $17 million Series E financing led by Novo A/S, a global life science investment firm.

22 May 2014

HealthWarehouse.com net sales decrease 28.8% in first quarter 2014

HealthWarehouse.com, Inc., the only VIPPS accredited online and mail-order pharmacy licensed in all 50 states, today announced financial results for the first quarter ended March 31, 2014.

22 May 2014

Neovasc reports record revenues in Q1 2014

Neovasc Inc. ("Neovasc" or the "Company"), today announced financial results for the three months ended March 31, 2014. "The first quarter of 2014 was marked by major developments at Neovasc," noted Alexei Marko, chief executive officer of Neovasc.

22 May 2014

IBM collaborates with Zambian Ministry of Health to provide life saving drugs to citizens

IBM today announced a collaboration with the Zambian Ministry of Health to provide citizens with improved access to 200 life saving drugs.

22 May 2014

Physicians Realty Trust prices public offering of common stock at $12.50 per share

Physicians Realty Trust ("the Company"), a self-managed healthcare real estate company, announced today the pricing of its public offering of 11,000,000 common shares of beneficial interest at a price to the public of $12.50 per share, for a total of approximately $129.5 million of net proceeds after deducting underwriting discounts and commissions and estimated offering expenses payable by the Company.

21 May 2014

Lucideon invests in an Agilent 7900 Quadrapole ICP-MS to extend its analysis techniques offerings

Lucideon, the international provider of materials development, testing and assurance, and formerly known as Ceram, is pleased to announce it has invested in the latest Agilent 7900 Quadrapole Inductively Coupled Plasma – Mass Spectrometry (ICP-MS).

From Lucideon 21 May 2014

Edison Pharmaceuticals' EPI-743 granted orphan designation for Leigh syndrome in Japan

Edison Pharmaceuticals has announced that the Japanese Ministry of Health, Labor and Welfare (MHLW) has granted Orphan Designation to EPI-743 for the treatment of Leigh syndrome.

21 May 2014

FDA approves Takeda's Entyvio for severe active ulcerative colitis and Crohn's disease

Takeda Pharmaceutical Company Limited and its wholly-owned subsidiary, Takeda Pharmaceuticals U.S.A., Inc., has announced that the United States (U.S.) Food and Drug Administration (FDA) simultaneously approved a new biologic therapy, Entyvio™ (vedolizumab), for the treatment of adults with moderately to severely active ulcerative colitis (UC) and Crohn's disease (CD).

21 May 2014

Marijuana Incubator Group to acquire VaporTownUsa.com

Marijuana Incubator Group, Inc. is pleased to announce that the Company has entered into meaningful negotiations for the purchase of VaporTownUsa.com, a profitable online vendor of top quality vapor related essentials.

20 May 2014

Business / Finance

National Surgical Hospitals purchases interest in The Fairfield Surgery Center

PCI | HealthDev adds Greg Pakes as Controller

MRA announces acquisition of TrustHCS's cancer registry services division

FDA postpones Dispute Resolution Panel for FzioMed’s Oxiplex PMA

Trimel announces top-line results of Phase II clinical trial evaluating efficacy of Tefina

Spokane Valley Cancer Center partners with SCCA Network to become 12th Member in Northwest

Twist Bioscience raises $26M in Series B financing, receives $5.1M DARPA contract

Alligator Bioscience acquires rights to drug development candidate ADC-1013

Abiogen Pharma, Lee's Pharma sign deal to market Neridronic Acid

Inovio Pharmaceuticals proposes 1-for-4 reverse split of common stock

Zimmer Holdings proposes to pay quarterly cash dividend to stockholders for Q2 of 2014

iRhythm Technologies closes $17 million Series E financing

HealthWarehouse.com net sales decrease 28.8% in first quarter 2014

Neovasc reports record revenues in Q1 2014

IBM collaborates with Zambian Ministry of Health to provide life saving drugs to citizens

Physicians Realty Trust prices public offering of common stock at $12.50 per share

Lucideon invests in an Agilent 7900 Quadrapole ICP-MS to extend its analysis techniques offerings

Edison Pharmaceuticals' EPI-743 granted orphan designation for Leigh syndrome in Japan

FDA approves Takeda's Entyvio for severe active ulcerative colitis and Crohn's disease

Marijuana Incubator Group to acquire VaporTownUsa.com

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Freezing Point Osmometry in Life Science Applications

Precision in every drop: Inside Hamilton’s syringe technology

Latest News